Neoadjuvant Chemotherapy and Radiotherapy in the Treatment of Advanced Head and Neck Cancer : Protocol Based Study

진행성 두경부암에서 선행항암요법과 방사선요법의 치료성적

  • Kim Chul-Ho (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Choi Jin-Hyuk (Department of Hemato-Oncology, Ajou University School of Medicine) ;
  • Lee Jin-Seok (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Oh Young-Taek (Department of Radiation Oncology, Ajou University School of Medicine)
  • 김철호 (아주대학교 의과대학 이비인후과교실) ;
  • 최진혁 (아주대학교 의과대학 혈액종양내과학교실) ;
  • 이진석 (아주대학교 의과대학 이비인후과교실) ;
  • 오영택 (아주대학교 의과대학 방사선종양학교실)
  • Published : 2004.11.01

Abstract

Background and Objectives: Standard treatment of locally advanced laryngeal, hypopharyngeal, and some oropharyngeal cancers includes total laryngectomy. In an attempt to preserve the larynx through induction chemotherapy, we designed induction chemotherapy followed by definitive radiation in patients with potentially respectable head and neck cancer to determine whether organ preservation is feasible without apparent compromise of survival. Materials and Methods: The twenty-six patients diagnosed advanced head and neck squamous cell carcinoma, Stage III or IV (AJCC 2002) and performed organ preservation protocols in Ajou university hospital from 1994 to 2001 were included in this study. Results: Neoadjuvant chemotherapy showed an overall response rate of 84.6% and a complete remission (CR) rate was 59.1% following neoadjuvant chemotherapy and radiation. Seven of thirteen patients were able to preserve their larynges for more than two years by chemotherapy and radiation. There were no treatment related mortality after 2 cycles of induction chemotherapy. Conclusion: Although Organ preservation protocol through neoadjuvant chemotherapy and radiation need more controlled randomized study, it was considered alternative treatment modality in advanced head and neck cancer.

Keywords

References

  1. Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE: Chemotherapy as a substitue for surgery in the treatment of advanced resectable head and neck cancer: A report from the northern california oncology group. Cancer. 1987;60:1178-1183 https://doi.org/10.1002/1097-0142(19870915)60:6<1178::AID-CNCR2820600604>3.0.CO;2-S
  2. Wolf GT, Hong WK, Fisher SG, et al: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690 https://doi.org/10.1056/NEJM199106133242402
  3. Urba S, Wolf G, Bradford C, et al: Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope. 2000;110:2074-2080 https://doi.org/10.1097/00005537-200012000-00019
  4. Pfister DG, Strong E, Hamson L, et al: Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol. 1991;9:850-859 https://doi.org/10.1200/JCO.1991.9.5.850
  5. Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690
  6. Kim KH, Sung MW, Koo JW, et al: Neoadjuvant chemotherapy and radiotherapy for the treatment of advanced hypopharyngeal carcinoma. Korean J Otolaryngol. 1997;40:429-434
  7. Nam TK, Park SJ, Ahn SJ, Chung WK, Nah BS: Results of conventionol radiotherapy in hypopharyngeal cancer. J Korean Soc Ther Radiol. 1995;13:143-147
  8. Beauvillain C, Mahe M, Bourdin S, et al: Finol results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinoma. Laryngoscope. 1997;107:648-653 https://doi.org/10.1097/00005537-199705000-00017
  9. Choi EC, Lee SY, Koh YW, et al: Treatment results and patterns of failure after surgery for the squamous cell carcinoma of hypopharynx. Korean J Otolaryngol. 2000;43:528-534
  10. Wang SG, Lee BJ, Goh EK, et al. Neoadjuvant chemotherapy and radiotherapy for the treatment of hypopharyngeal cancer. Korean J Otolaryngol. 2003;46:1058-1063
  11. Lee BJ, Lee HS, Jeon J, et al: Neoadjuvant chemotherapy and radiotherapy for the treatment of squamous cell carcinoma of the tonsil. Korean J Otolaryngol. 2002;45:1004-1009
  12. Forastiere AA, Maor M, Weber R, et al: Phase 111 trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone: Results of the Intergroup Trial R91-11. Proc Am Soc Clin Oncol. 20:2a, 2001 (abstr)